Gene Expression Profiling Identifies Downregulation of the Neurotrophin-MAPK Signaling Pathway in Female Diabetic Peripheral Neuropathy Patients

Table 1

Clinical and demographic characteristics of the participants.

	Control	T2DM	DPN
Discovery panel
Number	6	6	6
Gender	Female	Female	Female
Age (y)	51.17 ± 6.08	53.83 ± 10.80	57.33 ± 7.92
Fasting glucose (mmol/L)	5.10 ± 0.21	9.23 ± 2.02	9.95 ± 2.11
Validation panel
Number	26	26	26
Gender	Female	Female	Female
Age (y)	50.91 ± 5.60	51.25 ± 8.13	53.21 ± 11.15
Fasting glucose (mmol/L)	5.27 ± 0.59	8.96 ± 1.58	9.72 ± 1.81

The asterisks represent statistical significance () compared with the control group.